Gufic Biosciences Ltd.

ACTIVE

Indiawww.gufic.comPublic1,001–5,000 employeesEstablished: 1970-01-01

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1970

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

25.0%

Phase 3

25.0%

Unknown

12.5%

Trial Status Distribution

Active, not recruiting

12.5%

Completed

87.5%

Clinical Trials

Trials sponsored by this organization (8)

Evaluation of Botulinum Toxin in treatment of Forehead and Frown Lines

Active, not recruiting

interventional

Dec 202450 participants

Evaluating the Effectiveness of G-LiteÂ® Cream with CristelloÂ® Sunscreen in Treating Hyperpigmentation

Unknown

Completed

observational

Sep 202430 participants

To study the safety and efficacy of Botulinum toxin A in patients with (crowâ€™s feet) Wrinkles around the outer corner of eyes.

Completed

interventional

Sep 202250 participants

The DIVERSE Trial:Study to Evaluate the Efficacy and Safety of Dalbavancin in Comparison with Comparator Regimen (Vancomycin Followed by Linezolid) for the Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSIs).

Phase 3

Completed

interventional

Jan 2020268 participants

Clinical study to evaluate effectiveness, safety and efficacy of Nucart VG Tablet in treatment of Osteoarthritis.

Completed

interventional

Apr 201966 participants

Clinical study to evaluate effectiveness, safety and efficacy of Nucart VG Tablet in treatment of Osteoarthritis.

The DIVERSE Trial:Study to Evaluate the Efficacy and Safety of Dalbavancin in Comparison with Comparator Regimen (Vancomycin Followed by Linezolid) for the Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSIs).

To study the safety and efficacy of Botulinum toxin A in patients with (crow’s feet) Wrinkles around the outer corner of eyes.

Approvals

Approvals by Agency

PHILIPPINES

Philippines FDA

Approvals

Recent Approvals

News

No news articles found

Back to Organizations